![Carl Kraus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carl Kraus
Chief Tech/Sci/R&D Officer at
i3 Research, Inc.
Net worth: 1 M $ as of 31/05/2026
Profile
Carl N.
Kraus was the founder of Arrevus, Inc., founded in 2015, where the titles held included Chairman, President & Chief Executive Officer from 2017 to 2021.
The current job is Medical Director at i3 Research, Inc. Former jobs include Chief Medical Officer at Idera Pharmaceuticals, Inc., Chief Medical Officer at Resilience Government Services, Inc., Chief Medical Officer at Aceragen, Inc. from 2021 to 2023, and Chief Medical Officer at Aquestive Therapeutics, Inc. from 2023 to 2025.
Education includes undergraduate studies at Washington University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/10/2025 | 2,82,475 ( 0.23% ) | 1 M $ | 31/05/2026 |
Carl Kraus active positions
| Companies | Position | Start |
|---|---|---|
i3 Research, Inc.
 i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts oncology, central nervous system, and respiratory research | Chief Tech/Sci/R&D Officer | - |
Former positions of Carl Kraus
| Companies | Position | End |
|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 04/11/2025 |
| ACERAGEN, INC. | Chief Tech/Sci/R&D Officer | 30/04/2023 |
Arrevus, Inc.
 Arrevus, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies for orphan infectious diseases | Chief Executive Officer | 31/10/2021 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Chief Tech/Sci/R&D Officer | - |
Resilience Government Services, Inc.
 Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Operates as an integrated biopharmaceutical company | Chief Tech/Sci/R&D Officer | - |
Training of Carl Kraus
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Aquestive Therapeutics, Inc.
 Aquestive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes thin film pharmaceutical and over the counter drug products | Health Technology |
i3 Research, Inc.
i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts oncology, central nervous system, and respiratory research | Commercial Services |
Resilience Government Services, Inc.
Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Operates as an integrated biopharmaceutical company | Health Technology |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arrevus, Inc.
Arrevus, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies for orphan infectious diseases | Health Technology |
Aceragen, Inc.
 Aceragen, Inc. BiotechnologyHealth Technology Discovers, develops, and commercializes therapeutics for oncology and rare diseases | Health Technology |
- Stock Market
- Insiders
- Carl Kraus
